Comment on “Does the 5-2-1 criteria identify patients with advanced Parkinson’s disease? Real-world screening accuracy and burden of 5-2-1-positive patients in 7 countries”
Harmen R. Moes,
Erik Buskens,
Teus van Laar
Affiliations
Harmen R. Moes
Department of Neurology, University of Groningen, University Medical Center Groningen
Erik Buskens
Department of Epidemiology, University of Groningen, University Medical Center Groningen
Teus van Laar
Department of Neurology, University of Groningen, University Medical Center Groningen
Abstract The 5-2-1 criteria are intended to help general neurologists identify patients with advanced Parkinson’s disease who may benefit from treatment optimisation, such as with a device-aided therapy. Although the 5-2-1 criteria claim to address an unmet need, we urge readers to cautiously interpret the results of this validation study.
